Literature DB >> 12133661

Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

Attila T Lorincz1, Philip E Castle, Mark E Sherman, David R Scott, Andrew G Glass, Sholom Wacholder, Brenda B Rush, Patti E Gravitt, John E Schussler, Mark Schiffman.   

Abstract

Carcinogenic human papillomaviruses (HPV) are thought to be necessary for development of cervical cancer. We assessed whether higher viral loads of such viruses predicted future risk of CIN3 or cancer (CIN3+) in a cohort of 20810 women followed up for 10 years with cytological screening. We measured the viral load for 13 types of carcinogenic HPV (relative light units normalised to 1 pg/mL HPV 16 positive controls [RLU/PC]) using Hybrid Capture 2 testing of cervicovaginal lavages obtained at enrolment. Results were stratified into four groups (RLU/PC 1 to <10, 10 to <100, 100 to <1000, > or = 1000). Although presence of HPV strongly increased risk of CIN3+, high viral load did not further predict risk of CIN3+.

Entities:  

Mesh:

Year:  2002        PMID: 12133661     DOI: 10.1016/S0140-6736(02)09463-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease.

Authors:  Hsing-Pei Lin; Yang-Yang Huang; Hsueh-Yin Wu; Jau-Tsuen Kao
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.

Authors:  Christopher Payan; Alexandra Ducancelle; Mohamed H Aboubaker; Julien Caer; Malena Tapia; Amelie Chauvin; Damien Peyronnet; Elodie Le Hen; Zohra Arab; Marie-Christine Legrand; Adissa Tran; Edith Postec; Françoise Tourmen; Martine Avenel; Chantal Malbois; Marie-Anne De Brux; Philippe Descamps; Francoise Lunel
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

Review 3.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

4.  Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology.

Authors:  M Origoni; G Carminati; S Rolla; M Clementi; M Sideri; M T Sandri; M Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-01       Impact factor: 3.267

5.  Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China.

Authors:  Margaret Z Wang; Rui-Mei Feng; Shaoming Wang; Xian-Zhi Duan; Dong Li; Xun Zhang; Rong Mu; Youlin Qiao; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2019-08       Impact factor: 2.830

6.  High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger.

Authors:  Yuanchun Xu; Jorge Dotto; Yiang Hui; Kara Lawton; Kevin Schofield; Pei Hui
Journal:  Int J Clin Exp Pathol       Date:  2008-07-25

7.  A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting.

Authors:  Brandon J Lamere; Philip E Castle; Barbara Fetterman; Nancy Poitras; Mark Stanley; Jen Shieh; Thomas Lorey; Walter Kinney; Mark Schiffman
Journal:  J Virol Methods       Date:  2013-02-04       Impact factor: 2.014

8.  Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.

Authors:  Jo L K Cheung; T H Cheung; Julian W T Tang; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

9.  Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women.

Authors:  N Muñoz; G Hernandez-Suarez; F Méndez; M Molano; H Posso; V Moreno; R Murillo; M Ronderos; C Meijer; A Muñoz
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

10.  Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.

Authors:  Luisa Barzon; Colomba Giorgi; Franco M Buonaguro; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2008-12-16       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.